alfuzosin has been researched along with Stevens-Johnson Syndrome in 1 studies
alfuzosin: structure given in first source
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YS | 1 |
| Tay, YK | 1 |
| Kwok, C | 1 |
1 other study available for alfuzosin and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Diagnosis, Differential; Exanthema; Fever; Hu | 2006 |